Validation of the BeCare Multiple Sclerosis Assessment App
1 other identifier
observational
30
1 country
1
Brief Summary
This study involves data collection from use of the BeCare Link LLC mobile device app by subjects with Multiple Sclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2020
CompletedFirst Posted
Study publicly available on registry
February 27, 2020
CompletedStudy Start
First participant enrolled
February 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2023
CompletedDecember 23, 2022
December 1, 2022
1.8 years
February 22, 2020
December 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Clinical EDSS score vs MLA EDSS score comparison
To assess the efficacy of using a mobile application to perform routine assessments of neurological and physical functioning in subjects with MS by comparing clinically assigned EDSS scores with EDSS scores assigned by a single or multiple artificial intelligence techniques at various timed intervals
day 1 (initial visit)
Clinical EDSS score vs MLA EDSS score comparison
To assess the efficacy of using a mobile application to perform routine assessments of neurological and physical functioning in subjects with MS by comparing clinically assigned EDSS scores with EDSS scores assigned by a single or multiple artificial intelligence techniques at various timed intervals
90 days after day 1
Clinical EDSS score vs MLA EDSS score comparison
To assess the efficacy of using a mobile application to perform routine assessments of neurological and physical functioning in subjects with MS by comparing clinically assigned EDSS scores with EDSS scores assigned by a single or multiple artificial intelligence techniques at various timed intervals
180 days after day 1
Secondary Outcomes (2)
Disease Progression Measured by Change in EDSS score
weekly for 26 weeks
Development of a novel application to measure change in MS
18 months
Study Arms (2)
Clinical EDSS
The Kurtzke EDSS, is a clinical rating scale for multiple sclerosis having scores between 0 to 10 that are assigned by a trained clinician. Smaller impairments are assessed at lower scores and disability is assessed at higher scores. It is important to note, however, that despite being denoted on an ordinal scale, each level on the scale is not indicative of an equal change in disability.
MLA EDSS
The Kurtzke EDSS, is a clinical rating scale or multiple sclerosis having scores between 0 to 10 that are assigned by a technique based upon several different Machine Learning Algorithms that are combined to produce a single score
Eligibility Criteria
Patients with mild to moderate Multiple Sclerosis that can use a mobile app and are ambulatory.
You may qualify if:
- A history of Multiple Sclerosis, which will be verified through medical records and will be classified as clinically definite based on revised McDonald criteria
- Between the ages 18-75
- Mild to moderate disability in one or more of the modalities assessed by the BeCare App.
- Ability to provide Informed Consent.
You may not qualify if:
- Subjects at risk of falling
- Subjects with poor vision that cannot read the screen of a mobile phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- BeCare Link LLClead
- Yale Universitycollaborator
Study Sites (1)
Yale University School of Medicine
New Haven, Connecticut, 06520, United States
Related Publications (3)
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.
PMID: 21387374BACKGROUNDSebastiao E, Sandroff BM, Learmonth YC, Motl RW. Validity of the Timed Up and Go Test as a Measure of Functional Mobility in Persons With Multiple Sclerosis. Arch Phys Med Rehabil. 2016 Jul;97(7):1072-7. doi: 10.1016/j.apmr.2015.12.031. Epub 2016 Mar 2.
PMID: 26944709BACKGROUNDBerrigan LI, Fisk JD, Walker LA, Wojtowicz M, Rees LM, Freedman MS, Marrie RA. Reliability of regression-based normative data for the oral symbol digit modalities test: an evaluation of demographic influences, construct validity, and impairment classification rates in multiple sclerosis samples. Clin Neuropsychol. 2014;28(2):281-99. doi: 10.1080/13854046.2013.871337. Epub 2014 Jan 20.
PMID: 24438521BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharon Stoll, DO,MS
Yale University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2020
First Posted
February 27, 2020
Study Start
February 26, 2021
Primary Completion
December 20, 2022
Study Completion
February 20, 2023
Last Updated
December 23, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share